Syngene International: 7 Stock Signals Investors Are Watching Right Now

Syngene International CMP Rs 382.55. 52W range Rs 360.40-678.95. Mcap Rs 15,247 crore. PE 69.05 vs sector 68.95.

Syngene International stock signals are unusually layered right now, with the company trading at Rs 382.55, 43.7% below its 52-week high of Rs 678.95 and 6.1% above its 52-week low of Rs 360.40. Syngene International is a well tracked name in the contract research, development and manufacturing services space, and no single headline captures where the stock stands today.

This article does not make a buy, hold or sell call on Syngene International. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.

Click Here – Get Free Investment Predictions

Syngene International Stock at a Glance

Before going through each of the seven Syngene International stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.

1. Earnings Trend at Syngene International

Syngene International posted trailing-twelve-month revenue of Rs 3,678 crore versus Rs 3,809 crore a year earlier, while net profit moved to Rs 221 crore from Rs 317 crore, a change of -30.2% on the year. The most recent quarter added Rs 761.30 crore in revenue, a change of -14.7% year on year, against Rs -9.00 crore in net profit versus Rs 86.70 crore a year earlier.

the company swung to a net loss in the June 2026 quarter, down sharply year on year, as revenue fell close to 15%, extending trailing-twelve-month profit decline of over 30%. This is the first of the seven Syngene International stock signals worth tracking closely into the next results.

2. FII Holding in Syngene International

A full quarterly FII holding series was not available from the data source used here for Syngene International. Where that is the case, the most reliable next step is to check the company’s latest exchange filing directly, since a single-quarter snapshot can be misleading without the trend around it.

This is worth revisiting once the next quarterly shareholding disclosure is filed.

3. Promoter Holding in Syngene International

Promoter holding in Syngene International promoter and institutional shareholding figures were not available from the data source used here; investors can check the company’s latest exchange filing directly.

This is worth revisiting once the next quarterly shareholding disclosure is filed, to see whether the level and direction of change persists.

4. Debt Position at Syngene International

Syngene International’s debt to equity ratio stands at 0.09, one of the balance sheet metrics worth tracking alongside the earnings trend above. A lower or stable ratio generally gives more room to fund growth without leaning further on external borrowing, while a rising one is worth watching for its effect on finance costs.

This debt signal should be read alongside the valuation and corporate development signals below rather than in isolation, since capital raising plans can shift the picture from one quarter to the next.

5. Valuation of Syngene International Shares

At the current price, Syngene International trades at a price to earnings ratio of 69.05, a premium of close to 0.1% versus the sector average of 68.95. The price to book ratio stands at 3.15.

Whether that premium looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.

6. Technical Trend on the Syngene International Chart

The stock last traded around Rs 382.55, above its short-term average of about Rs 378.46, pointing to near-term strength. The 14-day RSI reads close to 40, in neutral territory. The MACD line sits below its signal line, a bearish momentum bias.

Over the past year the stock is currently 43.7% below its 52-week high of Rs 678.95 and 6.1% above its 52-week low of Rs 360.40. A sustained move back above its recent average would be an early technical sign of stabilisation.

7. Corporate Developments at Syngene International

Syngene International has revised its guidance lower due to a Zoetis offtake loss and client attrition in its Research Services business, with management acknowledging pricing pressure in commoditised research services, even as Goldman Sachs maintains an Accumulate rating citing an operational turnaround.

Check the Univest Screener for live fundamentals

What These Syngene International stock signals Mean Together

None of these seven signals on its own settles the debate on Syngene International. Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.

Investors weighing Syngene International would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in institutional positioning. Reading these Syngene International stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.

For context, investors following Syngene International often look at how the stock has moved through previous earnings cycles, how peer companies in the same space have reacted to similar corporate developments, and whether broader market conditions such as interest rate moves, sector-wide policy shifts or commodity price swings have played a larger role than company-specific news. None of these broader factors replace the seven signals above, but they help explain why a stock can move sharply even when no single company-specific trigger is visible in the data. Reading a stock’s price action purely in isolation, without this wider lens, can lead to drawing conclusions that do not hold up once the next quarter’s numbers or the next shareholding disclosure comes in. Investors are generally better served treating each of these seven factors as one input among several, updated on a rolling basis as new disclosures arrive, rather than as a one-time checklist filled in once and then set aside for the rest of the year without a further look.

Also Read: HDFC Bank: 7 Stock Signals Investors Are Watching Right Now

Conclusion

Syngene International currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Syngene International shares, and readers should form their own view based on their own research and risk appetite.

Download the Univest iOS App or Univest Android App to track Syngene International live price and more such signal based stock research.

FAQs on Syngene International Stock Signals

Why is Syngene International share price where it is right now?

Ans. Syngene International shares are trading 43.7% below their 52-week high of Rs 678.95 and 6.1% above their 52-week low of Rs 360.40, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.

What is Syngene International’s current FII holding?

Ans. A full quarterly FII holding series was not available for this article; check the company’s latest exchange filing directly.

Is Syngene International’s debt position a concern right now?

Ans. The debt to equity ratio stands at 0.09.

What is the promoter holding in Syngene International?

Ans. promoter and institutional shareholding figures were not available from the data source used here; investors can check the company’s latest exchange filing directly.

Is Syngene International expensive compared to its sector?

Ans. Syngene International trades at a price to earnings ratio of 69.05 against a sector average of 68.95.

What recent corporate developments are relevant to Syngene International?

Ans. Syngene International has revised its guidance lower due to a Zoetis offtake loss and client attrition in its Research Services business, with management acknowledging pricing pressure in commoditised research services, even as Goldman Sachs maintains an Accumulate rating citing an operational turnaround.

What do the technical charts suggest about Syngene International right now?

Ans. The stock is trading above its short-term average of about Rs 378.46, pointing to near-term strength, with its MACD line below its signal line, a bearish momentum bias.

Should investors buy Syngene International shares at current levels?

Ans. This article does not offer a buy, hold or sell recommendation. It lays out seven Syngene International stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.